Pharma Journalist
  • facebook
  • twitter
  • google_plus
  • Email
Pharma Journalist

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

AMRI Announces Strategic Alliance to Advance Mass Spectrometry Capabilities for Drug Discovery

Read more

GW Pharmaceuticals’ Cannabis-derived drug shows promise in brain cancer trial

Read more

Jazz enrolls first patient in JZP-110’s phase 2 trial for excessive sleepiness in PD patients

Read more

Quotient Clinical expands into USA through acquisition of SeaView Research, the specialist clinical pharmacology business

Read more

Aura Biosciences Receives FDA Clearance of Investigational New Drug Application for Light-activated AU-011 for the Treatment of Ocular Melanoma

Read more

Strata Oncology Announces Collaboration with Epizyme to Support Tazemetostat Clinical Development

Read more

Veeva rolls out cloud application to accelerate regulatory submission delivery

Read more

Portola Pharmaceuticals Signs $150 Million Royalty Agreement with HealthCare Royalty Partners for Development and Commercialization of Andexanet Alfa

Read more

Teva Confirms Generic Victoza Patent Challenge in the United States

Read more

Lysogene Receives Orphan Drug Designation from FDA for LYS-GM101

Read more

Posts pagination

Previous Page 1 of 936 … Page 919 of 936 … Page 936 of 936 Next
  • About
  • Advertise
  • Subscribe
  • Contact
View Desktop Version